Literature DB >> 19331311

Patterns of hospital resource utilization of children with leukemia and CNS tumors: a comparison of children who survive and those who die within 3 years of diagnosis.

Karrie Cummings Hendrickson1, Joan Rimar.   

Abstract

Hospital admissions for children with cancer tend to be longer than admissions for adults with cancer and longer, more frequent, and more costly than other pediatric admissions. The two childhood cancers most commonly requiring hospitalization are leukemia and tumors of the central nervous system (CNS tumors). Determining the best use of limited financial resources and preparing children and their parents for what to expect requires a better understanding of the patterns and cost of hospital resource utilization by children with cancer. Both hospital administrators and third-party payers can use this understanding to better allocate resources and plan the care of children with cancer in the future. Because many parents of children with cancer struggle financially due to the high cost of treatments, time off of work, and other non-medical expenses, more education in this area may help parents to prepare, thus alleviating some of the uncertainty and unexpected financial costs associated with childhood cancer.

Entities:  

Mesh:

Year:  2009        PMID: 19331311

Source DB:  PubMed          Journal:  Nurs Econ        ISSN: 0746-1739            Impact factor:   1.085


  3 in total

1.  Health Care Reform and Concurrent Curative Care for Terminally Ill Children: A Policy Analysis.

Authors:  Lisa C Lindley
Journal:  J Hosp Palliat Nurs       Date:  2011-03       Impact factor: 1.918

Review 2.  Bending the Cost Curve in Childhood Cancer.

Authors:  Heidi Russell; M Brooke Bernhardt
Journal:  Curr Hematol Malig Rep       Date:  2016-08       Impact factor: 3.952

3.  Algorithm for analysis of administrative pediatric cancer hospitalization data according to indication for admission.

Authors:  Heidi V Russell; M Fatih Okcu; Kala Kamdar; Mona D Shah; Eugene Kim; J Michael Swint; Wenyaw Chan; Xianglin L Du; Luisa Franzini; Vivian Ho
Journal:  BMC Med Inform Decis Mak       Date:  2014-10-01       Impact factor: 2.796

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.